baber/WOPTO huggingface dataset:
Patent NZ-336450-A (NZ)
Title: 3-aminocarbonyl / 3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
Inventor: KARDORFF UWE
IPC: C07C251/86
Filed: 1997-12-19
Abstract: Disclosed are 2-benzoylcyclohexane-1,3-diones of formula (I), wherein: R1 and R2 are hydrogen, nitro, halogen, cyano, thiocyanato, alkyl, haloalkyl, alkoxyalkyl, alkenyl, alkynyl, -OR5, -OCOR6, -OSO2R6, -SH, -S(O)nR7, -SO2OR5, -SO2NR5R8, -NR8SO2R6 or -NR8COR6; R3 is hydrogen, alkyl, haloalkyl, alkenyl or alkynyl; R4 is hydrogen, unsubstituted or substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, -COR9, -CO2R9, -COSR9 or -CONR8R9; X is oxygen or sulfur; z is oxygen or NR8; m is 0 or 1; n is 0, 1 or 2;. R5 is hydrogen, alkyl, haloalkyl, alkoxyalkyl, alkenyl or alkynyl; R6 is alkyl or haloalkyl; R7 is alkyl, haloalkyl, alkoxyalkyl, alkenyl or alkynyl; R8 is hydrogen or alkyl; R9 is alkyl, alkenyl, alkynyl, phenyl or benzyl; R10 is alkyl, haloalkyl, alkenyl or alkynyl; Q is an unsubstituted or substituted cyclohexane-1,3-dione ring which is linked in the 2-position; where m is 1 if R3 is hydrogen; Also disclosed are the processes and intermediates for the preparation of the compounds of formula I; compositions comprising them; and the use of these compositions for controlling undesired plants.
Patent NZ-338038-A (NZ)
Title: Patch bag having single seal through patches of predetermined minimum strength
Inventor: BOAL DILIP K
IPC: B65D75/26
Filed: 1998-04-03
Abstract: A patch bag  comprises a heat-shrinkable bag comprising a tubular bag film (18), and a heat-shrinkable patch (22) comprising a patch film, the patch being adhered to the bag, the patch bag having a seal (26) which is through both the patches as well as through both lay-flat sides of the bag. The seal has a strength of at least 26 inches of water and/or the bag is an end seal bag in which the seal through the patches is the only seal across the bottom of the bag. A process for making the bag includes sealing an inside surface of the film tubing to itself, the sealing being carried out by applying heat to each of the patch outside surfaces, the heat being applied by a first means for heating and a second means for heating, the first and second means for heating being in alignment with one another, with the patches and bag tubing therebetween during sealing
Patent NZ-502187-A (NZ)
Title: Procedure for setting up a secure service connection in a telecommunication system utilising a telephone network and the Internet to verify transactions
Inventor: VATANEN HARRI
IPC: H04W8/20
Filed: 1998-06-18
Abstract: The disclosed procedure is for setting up a secure service connection in a telecommunication system comprising: i) a first telecommunication network (1); ii) a first terminal device (2) connected to the first telecommunication network; iii) a second telecommunication network (3); iv) a second terminal device (4) connected to the second telecommunication network and v) a telecommunication server (5). The first terminal device is connected via a first telecommunication connection and the first telecommunication network to the telecommunication server and the second terminal device is connected via a second telecommunication connection and the second telecommunication network to the telecommunication server.  An unique address of the first terminal device and the data needed for verifying information giving the first terminal device access to the services of the telecommunication server are transmitted via the second terminal device. The data sent by the second terminal device is verified in the telecommunication server and the first telecommunication connection from the telecommunication server to the first terminal device is set up based on the verification and the address data received if the first terminal device has the required right of access to the services of the telecommunication server.
Patent NZ-504709-A (NZ)
Title: Drywall suspension grid system with drywall panels mounted to non faceted curved grid beams having integral continuous web portions
Inventor: WENDT ALAN C
IPC: E04B9/00
Filed: 1999-09-16
Abstract: A drywall suspension grid system comprising a selection of various sized and specified pre-formed and pre-engineered "T" grid beams and components used to construct a grid having a grid face upon which drywall is mounted, thus creating a suspended drywall ceiling. The suspension grid system can be used to create flat ceilings, curved ceilings, soffits, fascia for floating edge ceilings, utility interfaces, or any combination thereof in a suspended grid drywall ceiling.
Patent NZ-505969-A (NZ)
Title: Fuel additive composition, comprising solid compacting agent soluble in fuel and at least 40-99% of at least one liquid fuel additive, where the liquid fuel additive comprises at least one detergent additive selected from polyetheramines and polyalkeneamines
Inventor: JAKOB CLAUS PETER
IPC: C10L10/00
Filed: 1999-02-05
Abstract: A fuel additive composition comprises a homogeneous mixture of a solid compacting agent soluble in fuel and at least one liquid fuel additive.  The composition has a content of liquid fuel additive of from more than 40 to 99% by weight, based on its total weight.  The composition is solid or pasty under standard conditions of temperature and pressure.  The liquid fuel additive comprises at least one detergent additive, which is selected from the group consisting of polyetheramines and polyalkeneamines, in an amount of more than 10% by weight, based on the total weight of the formulation.
Patent NZ-507569-A (NZ)
Title: 2-Pyridyl substituted dihydropyrimidines useful for treating acute or chronic viral diseases
Inventor: WEBER OLAF
IPC: C07D401/14
Filed: 1999-04-07
Abstract: A dihydropyrimidine derivative or a salt thereof has the formula (I) or its isomeric form (Ia) wherein: R1 is optionally substituted phenyl, furyl, thienyl, pyridyl, cycloalkyl or a group of formula (2); R2 is -XR12 or -NR13R14; X is a bond or oxygen; R12, R13 and R14 are as defined in the specification; R3 is H, amino, -CH(OCH3)2, formyl, cyano, trifluoromethyl, pyridyl, an optionally substituted  straight chained, branched or cyclic hydrocarbon or optionally substituted phenyl or together R2 and R3 form a radical -O-CH2-; R4 is H, alkyl, alkenyl, benzoyl or acyl; R5 is pyridyl substituted up to 3 times independently by halo, hydroxy, cyano, trifluoromethyl, alkoxy, alkyl, alkylthio, carbalkoxy, acyloxy, amino, nitro, or alkylamino or dialkylamino. A pharmaceutical composition thereof its useful for treating acute or chronic viral diseases.
Patent NZ-508935-A (NZ)
Title: A method and device for creating a network positioning system (NPS)
Inventor: SMALL DAVID
IPC: G01S1/00
Filed: 1999-05-28
Abstract: A network positioning system (NPS) uses GNSS-like signals transmitted from a GNSS-synchronized network of terrestrially based, low cost positioning-unit devices. These positioning-unit devices are used for the determination of absolute and relative position in satellite obscured environments, thus allowing seamless transition between GNSS and NPS, e.g., outdoors to indoor. Positioning-unit devices are self-integrating, thus allowing effortless integration of positioning-unit devices into both the GNSS and the NPS network.
Patent NZ-509166-A (NZ)
Title: Piperazinone derivatives useful as antithrombotic agents
Inventor: YUE CHRISTOPHE
IPC: C07D401/12
Filed: 1999-07-16
Abstract: The invention concerns compounds of formula (I)wherein R1, R2, R3, R4 and R5 are as defined in the specification. Said compounds are useful in therapy as antithrombotic agents.
Patent NZ-509841-A (NZ)
Title: 4,4-biarylpiperidine derivatives having opioid receptor activity
Inventor: LIRAS SPIROS
IPC: C07D401/04
Filed: 1999-09-06
Abstract: A 4,4-biaryl piperdine derivative or a pharmaceutically acceptable salt thereof has the formula (I) wherein: R1 is hydrogen, alkoxyalkyl, cycloalkyl, or cycloalkylalkyl or optionally substituted aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclic or heterocyclic alkyl; the aryl of aryl and arylalkyl is phenyl or naphthyl; the heteroaryl of heteroaryl and heteroarylalkyl is pyrazinyl, benzofuranyl, quinolyl, isoquinolyl, benzothienyl, isobenzofuryl, pyrazolyl, indolyl, isoindolyl, benzimidazolyl, purinyl, carbazolyl, 1,2,5-thiadiazolyl, quinazolinyl, pyridazinyl, pyrazinyl, cinnolinyl, phthalazinyl, quinoxalinyl, xanthinyl, hypoxanthinyl, pteridinyl, 5-azacytidinyl, 5-azauracilyl, triazolopyridinyl, imidazolopyridinyl, pyrrolopyrimidinyl, pyrazolopyrimidinyl, oxazolyl, oxadiazoyl, isoxazoyl, thiazolyl, isothiazolyl, furanyl, pyrazolyl, pyrrolyl, tetrazolyl, triazolyl, thienyl, imidazolyl, pyridinyl, or pyrimidinyl; the heterocyclic of heterocyclic and heterocyclic alkyl is an optionally saturated or nonaromatic monocyclic ring system containing from four to seven ring carbon atoms with one to three of which may optionally be replaced with O, N or S or an optionally saturated or nonaromatic bicyclic ring system containing from seven to twelve ring carbon atoms with one to four of which may optionally be replaced with O, N or S; R2 is aryl, heteroaryl, heterocyclic, SO2R4, COR4, CONR5R6, COOR4, or C(OH)R5R6; R3 is hydroxy, NHSO2R7, C(OH)R7R8, fluorine or CONHR7; R4 to R8 are as defined in the specification and  Z1 and Z2 are independently, hydrogen, halo or alkyl; with the proviso that there are no two adjacent ring oxygen atoms and no ring oxygen atom adjacent to either a ring nitrogen atom or a ring sulphur atom in any of the heterocyclic or heteroaryl moieties of formula I. The compounds are useful in treating inflammatory diseases, disorders of respiratory function, gastrointestinal disorders, stroke, shock, brain edema, trauma, cerebral ischemia, cerebral deficits subsequent to cardiac bypass surgery and grafting, urogential tract disorders, chemical dependencies and addictions, pain, systemic lupus erythematosis, Hodgkin's disease, Sjogren's disease, epilepsy and rejection in organ transplants or skin grafts.
Patent NZ-510879-A (NZ)
Title: Method of cultivating aqua cultures with horizontal water level cable and submerged cables
Inventor: OLDHAM KEVIN CHARLES DAVID
IPC: A01K79/00
Filed: 2001-04-02
Abstract: A method of cultivating aquatic organisms, which comprises retaining a plurality of aquatic organisms on a submerged structure, the structure consisting of at least one first flexible elongate member connected to the ground by ground anchors attached to the two opposite ends thereof and connected to at least one flexible second elongate member by a plurality of connection members and at least one second flexible elongate member being or being provided with at least one upwardly buoyant member, wherein the aquatic organisms are suspended from the second flexible elongate member and the second flexible elongate member is held at an approximately horizontal position above the seabed.
Patent NZ-514521-A (NZ)
Title: Method of enhancing the efficacy of anti-tumor agents
Inventor: SILVER DAVID F
IPC: A61K33/243
Filed: 2000-04-24
Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.  Suitable hematocrit elevators include erythropoietin and erythropoietin-like substances, and suitable anti-tumor agents include platinum compounds such as cisplatin and carboplatin.
Patent NZ-518362-A (NZ)
Title: Air freshening apparatus
Inventor: KUHN PETRUS HENRICUS ALOYSIUS
IPC: A61L9/03
Filed: 2000-09-15
Abstract: An air freshening apparatus comprises a reservoir with a   wick,  which  reservoir  can  be  filled  with  a  fuel, particularly  with lamp oil, and heat conducting  means  for heat  transport from the wick, when burning, to  a  separate holder  for  an active component, such as a fragrance.   The holder may form an integral part of the apparatus or may  be replaceable,  in which case the apparatus is  provided  with connecting means to connect the holder to the apparatus.
Patent NZ-522825-A (NZ)
Title: Stabilised radiopharmaceutical composition comprising an amino-substituted aromatic carboxylic acid and a diphosphonic acid as stabilisers
Inventor: STOREY ANTHONY EAMON
IPC: A61K47/24
Filed: 2001-06-18
Abstract: A stabiliser for radiopharmaceuticals that inhibits impurities from being produced by two kinds of decomposition mechanisms and exhibits such an effect that the shelf life of a radiopharmaceutical after its preparation is prolonged as compared with conventional ones is disclosed. The stabilised radiopharmaceutical composition comprises a combination of an amino-substituted aromatic carboxylic acid or its salt, ester or amide in combination with a diphosphonic acid or its salt.
Patent NZ-523434-A (NZ)
Title: N-(2-phenyl-3-aminopropyl)naphthamides for use as neurokinin 1 (NK1) receptor antagonist
Inventor: BERNSTEIN PETER
IPC: A61P25/28
Filed: 2001-07-31
Abstract: A compound having the formula (I) and its pharmaceutically-acceptable salt is disclosed, wherein: R1 is H or CH3; R2 is H, halogen,-OR7 or C1-4alkyl; R3 is H, halogen, -OR7 or-CN; R4 is H, halogen, -OR7 or C1-4alkyl; R5 is H, C1-8alkyl, -C(=O)R9, -C(=O)OR8, -C(=O) N (R6) R8, -S(=O)nR9, cyanoguanidino or C1-4acylguanidino; R6 is, independently at each instance, H or C1-6alkyl; R7 is, independently at each instance, C1-6alkyl; R8 is H, C1-6alkyl substituted by 0,1 or 2 substituents selected from-OH and-NHR6 or C1-3alkyl substituted by 1,2,3 or 4 halogen atoms; R9 is, independently at each instance, C1-6alkyl substituted by 0,1 or 2 substituents selected from-OH and-NHR6 or C1-3alkyl substituted by 1,2,3 or 4 halogen atoms; n is 0,1 or 2; and X1 and X2 are independently H,-CH3 or halogen. These compounds antagonize the pharmacological actions of the neurokinin 1 (NK1) receptor and are useful for the treatment major depressive disorder, severe anxiety disorders, stress disorders, major depressive disorder with anxiety, eating disorders, bipolar disorder, substance use disorder, schizophrenic disorders, psychotic disorders, movement disorders, cognitive disorders, depression and/or anxiety, mania or hypomania, aggressive behaviour, obesity, emesis, rheumatoid arthritis, Alzheimer's disease, cancer, oedema, allergic rhinitis, inflammation, pain, gastrointestinal-hypermotility, Huntington's disease, chronic obstructive pulmonary disorder (COPD), hypertension, migraine, bladder hypermotility, or urticaria.
Patent NZ-524731-A (NZ)
Title: Particle coated bonding systems for hydratable cementitious composition casting and methods for making same
Inventor: WIERCINSKI ROBERT A
IPC: C09J195/00
Filed: 2001-08-06
Abstract: Coated articles, methods for making such articles, and waterproofing systems incorporating these. An exemplary coated article comprises a body with surface coating of inorganic particles reactive with hydroxide generated from hydration of concrete or mortar to form hydration products. The articles are designed to be used with cast concrete or masonry. The inorganic particles comprise at least one of (a) aluminum oxide trihydrate; (b) silica dioxide; (c) fly ash; (d) blast furnace slag, (e) silica fume; (f) an alkali or alkaline earth metal salts; or mixture thereof. The particles improve bonding with hydratable cementitious compositions that are cast against the coated surface and allowed to set.
Patent NZ-526243-A (NZ)
Title: Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
Inventor: YAN WEN LIANG
IPC: A61K35/12
Filed: 2001-11-30
Abstract: Pluripotent homozygous stem (HS) cells, and methods and materials for making same are described. Also provided are methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.
Patent NZ-528380-A (NZ)
Title: Wall cladding system
Inventor: FITZPATRICK JAMES
IPC: E04F13/08
Filed: 2003-09-22
Abstract: A wall cladding system, including a plurality of cladding tiles (11) and a plurality of support members (12). The support members are arranged to support the cladding tiles adjacent a wall in an array forming a generally planar outer facing cladding face. The cladding tiles include outer facing and rear engagement surfaces (30, 39) and are arranged to engage a pair of support members. The pair of support members are vertically spaced to support vertically opposite end regions of the tiles. The support members are operable to substantially restrain the tiles against movement toward and away from a wall. One of the pair of support members is operable support substantially the full weight of the tile.
Patent NZ-534473-A (NZ)
Title: Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders
Inventor: ARORA SUDERSHASN K
IPC: A61P37/02
Filed: 2003-01-10
Abstract: Disclosed is the use of a herbal composition comprising an effective amount of an extract of the leaves and/or stem of Argemone mexicana plant, containing organic constituents, in combination with pharmaceutically acceptable carriers, in the manufacture of a topical or oral medicament for the treatment of psoriasis and related biochemical and immunological disorders.
Patent NZ-536324-A (NZ)
Title: Coated abrasive tools that operate efficiently at moderate to low pressure grinding conditions by self-sharpening the cutting edges
Inventor: KNAPP CHRISTOPHER E
IPC: B24D3/00
Filed: 2003-03-21
Abstract: Disclosed is a coated abrasive article comprising a backing material and abrasive agglomerate grains adhered to the backing by a binder material, characterized in that the agglomerate grains used comprise a plurality of abrasive particles adhered together in a three dimensional structure in which each particle is joined to at least one adjacent particle by a particle binder material which is present in the agglomerate as a discontinuous phase in the form of bond posts within the agglomerate grain such that the agglomerate has a loose pack volume that is at least 2% lower than that of the abrasive particles in the individual state. Methods of preparing agglomerate grains and coated abrasives are also disclosed. These coated abrasives are characterized by a high porosity and low ratio of solid volume to nominal volume which provides exceptionally useful medium to low pressure grinding characteristics.
Patent NZ-539404-A (NZ)
Title: Pen device for administration of parathyroid hormone
Inventor: ROE MICHAEL JOSEPH
IPC: A61M5/315
Filed: 2001-09-26
Abstract: Disclosed is a pen delivery device comprising: a pen-shaped injector body having proximal and distal ends and a reservoir within the injector body; a rotatable dose knob attached to the proximal end of the injector body; and a pen needle removably attached to the distal end of the injector body; wherein parathyroid hormone is contained within the reservoir; said injector body having a first hard stop to prevent dose delivery of more than a preset single maximum injectable dose of the parathyroid hormone; and wherein the dose knob is marked with step designations for a step-by-step method of administering the parathyroid hormone, said step designations including only two dosage step designations corresponding to two respective predetermined dosages, said two dosage step designations being a first dosage step designation corresponding to a single predetermined priming dosage and a second dosage step designation corresponding to a single injection dosage, which single injection dosage is the preset single maximum injectable dose.
Patent NZ-539966-A (NZ)
Title: A new method for storing data
Inventor: DOYLE MARK
IPC: G06F19/00
Filed: 2003-10-15
Abstract: A method for storing data comprising the steps of providing website with a database, storing data regarding a plurality of individuals on the database, whereby a plurality of personal files are established with each personal file having data relating to a service provider and data relating to a service provided to the individual by the service provider, storing data relating to at least one product used in the service provided by the service provider, storing a notification of consent for the provision of the service to the individual, whereby each personal file is accessible by the individual for that file by using a personal password and by the service provider for that individual by using a service provider password and recording in the personal file of the individual, after the individual has received service, data relating to the condition of the individual.
Patent NZ-544330-A (NZ)
Title: Sulfonamide substituted imidazoquinolines
Inventor: GREISGRABER GEORGE W
IPC: C07C/
Filed: 2004-06-25
Abstract: Disclosed is N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl}-1,1-dimethylethyl}methanesulfonamide, a compound useful in the treatment of viral and neoplastic diseases.
Patent NZ-548524-A (NZ)
Title: Use of cyclic oligomers in a shaping process, and moldings produced by this process
Inventor: MONSHEIMER SYLVIA
Filed: 2006-07-14
Abstract: A process for the production of moldings via a layer-by-layer process in which the regions of the respective powder layer are selectively melting via input of electromagnetic energy, and permitting the layers to solidify to provide a solid mass, wherein selectivity is achieved via application of an aid selected from the group consisting of susceptors, inhibitors, absorbers, masks, and focusing of a laser beam, wherein the process comprises using powder which comprises cyclic oligomers.
Patent NZ-549893-A (NZ)
Title: Use of anti-alpha5beta1 antibodiesin a stabilising solution to inhibit cancer cell proliferation
Inventor: RAMAKRISHNAN VANITHA
IPC: C07K16/28
Filed: 2005-03-24
Abstract: Disclosed is the use of: about 1.0 mg/mL to 15 mg/mL anti-alpha5beta1 antibody; about 22 mM to 27 mM citrate; about 145 mM to 165 mM sodium chloride; and about 0.04% to 0.06% polysorbate 80; in the manufacture of a medicament for inhibiting the proliferation of a cancer cell, wherein the cancer cell expresses alpha5beta1 integrin on its surface, and wherein the medicament is a liquid formulation and has a pH of about 5.5 to 7.5.
Patent NZ-554282-A (NZ)
Title: Speaker for a communications apparatus
Inventor: MIRANDA STEPHEN ALFRED
IPC: H04B1/38
Filed: 2003-09-05
Abstract: A speaker enclosure includes a housing including a speaker and the housing defining at least one opening; a resilient diaphragm that is attached to the housing and that is configured to make contact with the head of a person, in use; and a membrane that is arranged on the housing to seal the at least one opening so that the speaker is shielded from the water.